Company news: GlaxoSmithKline

Share this article:
GlaxoSmithKline is readying another round of R&D cuts and giving its Research Triangle Park workforce a haircut, with plans to eliminate positions at its Neurosciences Medicine Development Center, according to the News & Observer of Raleigh, NC. Less than 50 R&D jobs are being eliminated nationwide, with fewer than half of those coming from Research Triangle Park and Philadelphia emerging largely unscathed. It's a drop in the bucket after years of deep cuts at the company, which has cut 22,000 jobs worldwide between 2007 and 2010, the newspaper reported.
Share this article:

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.